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Patients with end stage renal disease undergoing regular hemodialysis very often suffer 
from oxidative stress, which is defined as a state where the production of reactive oxygen species 
exceeds the capacity of the antioxidant defense systems in the cells and tissues. It has been 
observed that the free radical induced lipid peroxidation can further lead to a significant tissue 
damage, which plays role in the pathogenesis of various co-morbidities in the hemodialysis patients. 
The aim of this study was to determine the plasma levels of total hydroperoxides in 
hemodialysis patients before the single hemodialysis session (N=13) in comparison with healthy 
persons (N=38), using an in-house PerOx assay, as an indication and quantification of the plasma 
oxidative status/oxidative stress. The determination of plasma hydroperoxides was performed by 
their reaction with horseradish peroxidase, followed by conversion of tetramethylbenzidine (TMB) 
into a colored product. Commercial standards with known concentrations of H2O2 in plasma matrix 
were used for calibration of the assay. 
The results from the PerOx assay have shown that hemodialysis patients have significantly 
higher concentrations of plasma hydroperoxides (287±84 CARR U) than healthy subjects (238±65 
CARR U) p<0.05 (one CARR U corresponds to 0.08 mg/100mL H2O2). These results indicate that the 
PerOx assay reflects an increased oxidative stress which is related to the end stage renal disease and 
chronic hemodialysis. 
Further analyses are needed to establish the value of this assay with regards of the effects of 
the single hemodialysis session, the possible antioxidant supplementation and the comorbidities in 
the hemodialysis patients. 
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